Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains (Q59509407)
Jump to navigation
Jump to search
scientific article published on 30 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains |
scientific article published on 30 March 2012 |
Statements
Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains (English)
Javier Molina-Infante
Carmen Pazos-Pacheco
Gema Vinagre-Rodriguez
Belen Perez-Gallardo
Carmen Dueñas-Sadornil
Moisés Hernandez-Alonso
Guadalupe Gonzalez-Garcia
Jose M Mateos-Rodriguez
30 March 2012